106 related articles for article (PubMed ID: 6537908)
1. Azthreonam activity against gram-negative bacilli.
Bremner DA
Chemotherapy; 1984; 30(1):44-8. PubMed ID: 6537908
[TBL] [Abstract][Full Text] [Related]
2. The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin.
Elliott TS; Greenwood D
J Med Microbiol; 1984 Apr; 17(2):159-69. PubMed ID: 6423826
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
Appelbaum PC; Tamim J; Pankuch GA; Aber RC
Chemotherapy; 1983; 29(5):337-44. PubMed ID: 6311492
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Braveny I; Machka K; Elsser R
Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
[TBL] [Abstract][Full Text] [Related]
5. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
6. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
Le Noc P; Robert J; Le Noc D
Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of azthreonam, a monobactam antibiotic.
Jacobus NV; Ferreira MC; Barza M
Antimicrob Agents Chemother; 1982 Nov; 22(5):832-8. PubMed ID: 6891198
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
9. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.
Strandberg DA; Jorgensen JH; Drutz DJ
Antimicrob Agents Chemother; 1983 Aug; 24(2):282-6. PubMed ID: 6685453
[TBL] [Abstract][Full Text] [Related]
10. Belgian multicentre study on the in vitro activity of cefepime against gram-negative bacilli.
Verbist L; Glupczynski Y
Acta Clin Belg; 1996; 51(1):28-35. PubMed ID: 8669160
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
Verbist L; Verhaegen J
Antimicrob Agents Chemother; 1981 Mar; 19(3):402-6. PubMed ID: 6264844
[TBL] [Abstract][Full Text] [Related]
12. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
13. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
14. Azthreonam: in vitro activity against urinary pathogens.
Lang SD; McKenzie D
Pathology; 1983 Apr; 15(2):159-60. PubMed ID: 6412200
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.
Verbist L
Antimicrob Agents Chemother; 1981 Mar; 19(3):407-13. PubMed ID: 6972728
[TBL] [Abstract][Full Text] [Related]
16. In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
Cynamon MH; Granato PA
Chemotherapy; 1982; 28(3):204-8. PubMed ID: 6212205
[TBL] [Abstract][Full Text] [Related]
17. Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
Tumah H
Chemotherapy; 2005 May; 51(2-3):80-5. PubMed ID: 15870501
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of community hospital blood culture isolates of gram-negative bacilli.
Gordon RC; Tack KJ; Haddy RI; Fechner L; Wofford R
Chemotherapy; 1984; 30(1):40-3. PubMed ID: 6420120
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of azthreonam on hospital Gram-negative bacilli. Results of a multicenter study].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J; Thabaut A; Meyran M; Acar JF; Kitzis MD; Chanal M; Cluzel M; Morel C
Pathol Biol (Paris); 1983 Jun; 31(6):488-91. PubMed ID: 6348655
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
